Intraoperative Neuro-monitoring Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Intraoperative-Neuro-monitoring-Market

Intraoperative neuromonitoring referred as intraoperative neurophysiological monitoring (IOM), is an integral part of surgical procedures that use electrophysiological techniques such as electromyography (EMG), Electroencephalography (EEG), and evoked potentials to monitor the integrity of the neural structures. These neural structures include neurons, spinal cord and several parts of the brain. The IONM helps in the risk reduction from the iatrogenic damage to the nervous system during the surgical procedures by surgeons and anesthesiologists. The intraoperative neuromonitoring techniques have helped to reduce the mortality and morbidity levels to a significant rate without the new addition of risks. Therefore, the intraoperative neuromonitoring techniques have helped to reduce the costs of health care.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/939

The iatrogenic damages during surgical processes responsible to fuel the demand for the intraoperative neuromonitoring systems

According to a fact sheet of 2015 by Sci-Info-Pages, 12500 new spinal cord injuries occur each year and nearly 300,000 people in the United States are currently living with the spinal cord injuries. Also, as per a scientific paper published in 2014,  Deutsches Arzteblatt suggests that the iatrogenic nerve injuries accounted for 17.4% of the total traumatic nerve injuries. Moreover, according to World Health Organization (WHO) factsheet of 2015, 80% disorders in the disabling conditions are neurological. These high incidence rates of nerve and spinal cord injuries can be lowered down with the use of intraoperative neuro monitoring due to the alerts provided as early warnings regarding the sensory and motor functions. This leads to the reduction in the chances of manual errors by surgeons while performing a neural procedure.

The Outsource intraoperative neuromonitoring segment is anticipated to show dramatic growth in the forecast period

The global intraoperative neuromonitoring market can be segmented on the basis of type of monitoring and geography.

On the basis of type, the global intraoperative neuromonitoring market is segmented into

  • Insource Intraoperative Neuromonitoring System
  • Outsource Intraoperative Neuromonitoring System

The Outsource IONM is the fastest growing segment as well as gaining popularity due to the constant modifications leading to the improved performances of these systems. The additional benefit of outsourcing the intraoperative neuromonitoring systems is that it eliminates the cost of purchase and cost of maintenance for these systems by the hospitals making them a more preferred option than the currently dominating insource intraoperative neuromonitoring systems.

Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/939

North America dominating the global intraoperative neuromonitoring market owing to consistent development within the field

Based on the geography, the global intraoperative neuromonitoring system can be segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. The North America accounts for maximum share in the global intraoperative neuromonitoring market followed by Europe. This attributes to a constantly improving scenario in these regions in terms of reimbursement. The patients are benefitted by the insurance companies  with the clear defined codes of the procedures, making it easy and convenient.  Additionally, the vivid guidelines mentioned in the implementation of neuromonitoring systems makes the job easy for the hospitals and the medical personnel. However, Asia Pacific is anticipated to exhibit maximum growth in the forecast years owing to the growth of awareness among people about safety and precautions to be taken during surgery as well as rising medical tourism in these countries.

Vivid reimbursement policies making the global IONM market to accelerate the demands

The high probabilities of major surgeries to pose a risk to the nervous system that necessitates the intraoperative neuromonitoring is the prime reason to drive the global intraoperative neuromonitoring market. Moreover, the favorable reimbursement scenario is also responsible to fuel the market growth. However, the lack of skilled persons and technicians to operate these systems as well as the unawareness about the neuromonitoring facilities in the developing countries are some factors that are responsible to restrain the growth of the global intraoperative neuromonitoring market.

The dominant players involved in acquisition policies for expansion of the IONM services

The key players operating the global intraoperative neuromonitoring market includes Accurate Monitoring, Neuromonitoring Technologies, Natus Medical Incorporated, Medtronic LLC, Biotronic NeuroNetwork, NuVasive Inc., Sentient Medical Systems, and SpecialityCare. The dominant players are indulged in acquiring smaller companies so as to expand the product offering as well as to establish a strong geographical presence in the global intraoperative neuromonitoring market. For instance, the NuVasive, Inc. was acquired by Biotronic NeuroNetwork LLC for the expansion of Insource and Outsource IONM services.

You may be interested

Medical Cannabis Market | Global Trends, and Forecast to 2025
Healthcare
Healthcare

Medical Cannabis Market | Global Trends, and Forecast to 2025

Albert R - April 21, 2018

Increasing approval of medicinal cannabis products and growing research and development activities in the medical cannabis market are expected to support the growth of the market. For…

Familial Amyloid Cardiomyopathy Treatment Market-Moving Towards a Brighter Future
Healthcare
Healthcare

Familial Amyloid Cardiomyopathy Treatment Market-Moving Towards a Brighter Future

Albert R - April 21, 2018

Aggregation and deposition of mutant and wild-type transthyretin protein (TTR) in heart results in familial amyloid cardiomyopathy, which typically occur after age of 60. Familial amyloid cardiomyopathy…

3D Cell Culture Market To Witness Robust Expansion by 2024
Healthcare
Healthcare

3D Cell Culture Market To Witness Robust Expansion by 2024

Albert R - April 21, 2018

3D cell culture is group of biological cells that are allowed to grow in artificial media in all three dimensions. It is used in drug discovery and…

Most from this category